CurrentCardio coverage · page 3 of 15

European Journal of Heart Failure

Briefs 81–120 of 588 CurrentCardio has covered from this journal, newest publication first

Latest from European Journal of Heart Failure

All coverage, newest first

Eur J Heart Fail21 Apr 2026
Impact of multicomponent exercise training in older individuals with and without heart failure with reduced ejection fraction: the role of functional capacity and novel biomarkers
Secondary analysisHeart failure
Eur J Heart Fail16 Apr 2026
Exercise cardiac magnetic resonance biventricular volumetric reserve in heart failure with preserved ejection fraction
Cohort studyHeart failure
Eur J Heart Fail16 Apr 2026
Hemodynamic changes in response to GLP-1 treatment in ICD and CRT patients: insights from HeartLogic sensor data
Cohort studyHeart failure
Eur J Heart Fail13 Apr 2026
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA
Secondary analysisArrhythmias & EP
Eur J Heart Fail8 Apr 2026
Effects of finerenone across a range of heart failure duration: a prespecified analysis of the FINEARTS-HF trial
Secondary analysisHeart failure
Eur J Heart Fail8 Apr 2026
Kidney failure risk equation and risk of kidney and cardiovascular outcomes in patients with heart failure with reduced ejection fraction: insights from PARADIGM-HF
Secondary analysisHeart failure
Eur J Heart Fail8 Apr 2026
Spironolactone, early acute eGFR changes, and clinical outcomes in patients with heart failure with preserved ejection fraction: insights from TOPCAT Americas
Secondary analysisHeart failure
Eur J Heart Fail7 Apr 2026
AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: rationale and study design of the GenePHIT trial
Trial designHeart failure
Eur J Heart Fail7 Apr 2026
European Journal of Heart Failure International Expert Position Paper—Utilization, optimization, and clinical benefits of steroidal mineralocorticoid receptor antagonists in heart failure with a reduced ejection fraction
Guideline or statementHeart failure
Eur J Heart Fail7 Apr 2026
The global epidemiology of heart failure: a comprehensive and contemporary review
Research articleHeart failure
Eur J Heart Fail30 Mar 2026
Insights into the renin–angiotensin–aldosterone system in transthyretin amyloid cardiomyopathy
Cohort studyHeart failure
Eur J Heart Fail29 Mar 2026
Effect of vutrisiran on components of health status in transthyretin amyloidosis with cardiomyopathy: the HELIOS-B study
Secondary analysisHeart failure
Eur J Heart Fail26 Mar 2026
Effect of age on 5-year excess mortality in heart failure with reduced ejection fraction
Cohort studyHeart failure
Eur J Heart Fail24 Mar 2026
Liver-related outcomes in patients with tricuspid regurgitation
Cohort studyValvular & structural
Eur J Heart Fail20 Mar 2026
Comparative diagnostic performance of machine learning models and traditional scores for HFpEF in older adults
Diagnostic or prognostic studyHeart failure
Eur J Heart Fail14 Mar 2026
Finerenone, eplerenone, and spironolactone in heart failure with preserved ejection fraction: a Bayesian network meta-analysis of efficacy and safety
Meta-analysisHeart failure
Eur J Heart Fail14 Mar 2026
Left-sided heart failure determines outcomes in patients with severe tricuspid regurgitation undergoing percutaneous repair
Cohort studyValvular & structural
Eur J Heart Fail13 Mar 2026
Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial
Randomised controlled trialHeart failure
Eur J Heart Fail13 Mar 2026
Prevalence and influence of cardiovascular kidney metabolic syndrome on outcomes after transcatheter aortic valve implantation
Cohort studyValvular & structural
Eur J Heart Fail12 Mar 2026
Comprehensive evaluation of hypertrophic cardiomyopathy: European Journal of Heart Failure expert consensus document
Guideline or statementHeart failure
Eur J Heart Fail12 Mar 2026
Finerenone and quality of life in heart failure: component-level analyses and clinical relevance of the Kansas City cardiomyopathy questionnaire
Secondary analysisHeart failure
Eur J Heart Fail11 Mar 2026
Are β-blockers necessary for patients with heart failure with preserved ejection fraction? PURSUIT-HFpEF registry
Cohort study
Eur J Heart Fail9 Mar 2026
Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESC
Guideline or statementCongenital
Eur J Heart Fail9 Mar 2026
Target-dose vs below-target-dose ACE inhibitors and lower risk of kidney failure and mortality in US Veterans with HFrEF
Cohort studyHeart failure
Eur J Heart Fail5 Mar 2026
Characterizing the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from risk
Cohort studyHeart failure
Eur J Heart Fail5 Mar 2026
Enhancing heart failure care through registries: lessons learned from Nordic Countries’ implementation of guidelines
Research articleHeart failure
Eur J Heart Fail5 Mar 2026
Recurrence of peripartum cardiomyopathy in subsequent pregnancy stratified by left ventricular function: a systematic review and meta-analysis
Meta-analysisCardio-oncology & other
Eur J Heart Fail3 Mar 2026
The yield and clinical impact of genetic testing in older patients with dilated cardiomyopathy
Cohort studyHeart failure
Eur J Heart Fail28 Feb 2026
Genitourinary tract infections and SGLT2 inhibitors in heart failure: an EMPEROR-Pooled analysis
Secondary analysisHeart failure
Eur J Heart Fail24 Feb 2026
Combination of heart failure and atrial fibrillation worsens ethnicity-related disparity: an individual patient-level meta-analysis of randomized trials
Meta-analysisHeart failure
Eur J Heart Fail20 Feb 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: observations from ATTRibute-CM
Secondary analysisHeart failure
Eur J Heart Fail19 Feb 2026
Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction
Cohort studyHeart failure
Eur J Heart Fail12 Feb 2026
Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial
Secondary analysisHeart failure
Eur J Heart Fail10 Feb 2026
Association of SGLT2 inhibitors and new-onset dementia in non-diabetic patients with heart failure
Cohort studyHeart failure
Eur J Heart Fail10 Feb 2026
Coexistence of atrial fibrillation and metabolic dysfunction-associated steatotic liver disease as a high-risk overlap for incident heart failure in older adults
Cohort studyArrhythmias & EP
Eur J Heart Fail10 Feb 2026
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial
Secondary analysisHeart failure
Eur J Heart Fail10 Feb 2026
Outcome trajectories in hospitalized heart failure with preserved ejection fraction: a machine learning cluster analysis
Cohort studyHeart failure
Eur J Heart Fail6 Feb 2026
Surrogate markers of clinical endpoints in clinical trials of heart failure
Meta-analysisHeart failure
Eur J Heart Fail4 Feb 2026
Implementation of guideline-directed medical therapy in patients with heart failure and obesity: European Journal of Heart Failure expert consensus document
Guideline or statementHeart failure
Eur J Heart Fail2 Feb 2026
Clinical characteristics and outcomes of cardiomyopathies related to immune-mediated diseases
Cohort studyHeart failure

All 588 Briefs in ExploreShowing Briefs 81–120 of 588, newest first